Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis
- Autores
- Martin, Anandi; Paasch, Fabienne; Docx, Sven; Fissette, Krista; Imperiale, Belén Rocío; Ribón, Wellman; González, Liliana Andrea; Werngren, Jim; Engström, Anna; Skenders, Girts; Juréen, Pontus; Hoffner, Sven; Del Portillo, Patricia; Morcillo, Nora Susana; Palomino, Juan Carlos
- Año de publicación
- 2011
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Objectives: To perform a multicentre study to evaluate the performance of the colorimetric redox indicator (CRI) assay and to establish the MICs and critical concentrations of rifampicin, isoniazid, ofloxacin, kanamycin and capreomycin. Methods: The study was carried out in two phases. Phase I determined the MIC of each drug. Phase II established critical concentrations for the five drugs tested by the CRI assay compared with the conventional proportion method. Results: Phase I: a strain was considered resistant by the CRI assay if the MIC was 0.5 mg/L for rifampicin, 0.25 mg/L for isoniazid, 4.0 mg/L for ofloxacin and 5.0 mg/L for kanamycin and capreomycin. Sensitivity was 99.1% for isoniazid and 100% for the other drugs and specificity was 97.9% for capreomycin and 100% for the other drugs. Phase II: the critical concentration was 0.5 mg/L for rifampicin, 0.25 mg/L for isoniazid, 2.0 mg/L for ofloxacin and 2.5 mg/L for kanamycin and capreomycin giving an overall accuracy of 98.4%, 96.6%, 96.7%, 98.3% and 90%, respectively. Conclusions: Results demonstrate that the CRI assay is an accurate method for the rapid detection of XDR Mycobacterium tuberculosis. The CRI assay is faster than the conventional drug susceptibility testing method using solid medium, has the same turnaround time as the BACTEC MGIT 960 system, but is less expensive, and could be an adequate method for low-income countries.
Fil: Martin, Anandi. Institute of Tropical Medicine; Bélgica
Fil: Paasch, Fabienne. Institute of Tropical Medicine; Bélgica
Fil: Docx, Sven. Institute of Tropical Medicine; Bélgica
Fil: Fissette, Krista. Institute of Tropical Medicine; Bélgica
Fil: Imperiale, Belén Rocío. Provincia de Buenos Aires. Ministerio de Salud. Hospital "Dr. Antonio A. Cetrángolo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Ribón, Wellman. Universidad Industrial Santander; Colombia
Fil: González, Liliana Andrea. Universidad Industrial Santander; Colombia
Fil: Werngren, Jim. Swedish Institute for Infectious Disease Control; Suecia
Fil: Engström, Anna. Swedish Institute for Infectious Disease Control; Suecia
Fil: Skenders, Girts. No especifíca;
Fil: Juréen, Pontus. Swedish Institute for Infectious Disease Control; Suecia
Fil: Hoffner, Sven. Swedish Institute for Infectious Disease Control; Suecia
Fil: Del Portillo, Patricia. No especifíca;
Fil: Morcillo, Nora Susana. Provincia de Buenos Aires. Ministerio de Salud. Hospital "Dr. Antonio A. Cetrángolo"; Argentina
Fil: Palomino, Juan Carlos. Institute of Tropical Medicine; Bélgica - Materia
-
DRUG RESISTANCE
RESAZURIN
SECOND-LINE DRUGS
TUBERCULOSIS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/192105
Ver los metadatos del registro completo
id |
CONICETDig_772b9da76190169435a4969791e880b6 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/192105 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosisMartin, AnandiPaasch, FabienneDocx, SvenFissette, KristaImperiale, Belén RocíoRibón, WellmanGonzález, Liliana AndreaWerngren, JimEngström, AnnaSkenders, GirtsJuréen, PontusHoffner, SvenDel Portillo, PatriciaMorcillo, Nora SusanaPalomino, Juan CarlosDRUG RESISTANCERESAZURINSECOND-LINE DRUGSTUBERCULOSIShttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Objectives: To perform a multicentre study to evaluate the performance of the colorimetric redox indicator (CRI) assay and to establish the MICs and critical concentrations of rifampicin, isoniazid, ofloxacin, kanamycin and capreomycin. Methods: The study was carried out in two phases. Phase I determined the MIC of each drug. Phase II established critical concentrations for the five drugs tested by the CRI assay compared with the conventional proportion method. Results: Phase I: a strain was considered resistant by the CRI assay if the MIC was 0.5 mg/L for rifampicin, 0.25 mg/L for isoniazid, 4.0 mg/L for ofloxacin and 5.0 mg/L for kanamycin and capreomycin. Sensitivity was 99.1% for isoniazid and 100% for the other drugs and specificity was 97.9% for capreomycin and 100% for the other drugs. Phase II: the critical concentration was 0.5 mg/L for rifampicin, 0.25 mg/L for isoniazid, 2.0 mg/L for ofloxacin and 2.5 mg/L for kanamycin and capreomycin giving an overall accuracy of 98.4%, 96.6%, 96.7%, 98.3% and 90%, respectively. Conclusions: Results demonstrate that the CRI assay is an accurate method for the rapid detection of XDR Mycobacterium tuberculosis. The CRI assay is faster than the conventional drug susceptibility testing method using solid medium, has the same turnaround time as the BACTEC MGIT 960 system, but is less expensive, and could be an adequate method for low-income countries.Fil: Martin, Anandi. Institute of Tropical Medicine; BélgicaFil: Paasch, Fabienne. Institute of Tropical Medicine; BélgicaFil: Docx, Sven. Institute of Tropical Medicine; BélgicaFil: Fissette, Krista. Institute of Tropical Medicine; BélgicaFil: Imperiale, Belén Rocío. Provincia de Buenos Aires. Ministerio de Salud. Hospital "Dr. Antonio A. Cetrángolo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Ribón, Wellman. Universidad Industrial Santander; ColombiaFil: González, Liliana Andrea. Universidad Industrial Santander; ColombiaFil: Werngren, Jim. Swedish Institute for Infectious Disease Control; SueciaFil: Engström, Anna. Swedish Institute for Infectious Disease Control; SueciaFil: Skenders, Girts. No especifíca;Fil: Juréen, Pontus. Swedish Institute for Infectious Disease Control; SueciaFil: Hoffner, Sven. Swedish Institute for Infectious Disease Control; SueciaFil: Del Portillo, Patricia. No especifíca;Fil: Morcillo, Nora Susana. Provincia de Buenos Aires. Ministerio de Salud. Hospital "Dr. Antonio A. Cetrángolo"; ArgentinaFil: Palomino, Juan Carlos. Institute of Tropical Medicine; BélgicaOxford University Press2011-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/192105Martin, Anandi; Paasch, Fabienne; Docx, Sven; Fissette, Krista; Imperiale, Belén Rocío; et al.; Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis; Oxford University Press; Journal of Antimicrobial Chemotherapy; 66; 4; 4-2011; 827-8330305-7453CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://academic.oup.com/jac/article/66/4/827/723957info:eu-repo/semantics/altIdentifier/doi/10.1093/jac/dkq527info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:06:08Zoai:ri.conicet.gov.ar:11336/192105instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:06:08.747CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis |
title |
Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis |
spellingShingle |
Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis Martin, Anandi DRUG RESISTANCE RESAZURIN SECOND-LINE DRUGS TUBERCULOSIS |
title_short |
Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis |
title_full |
Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis |
title_fullStr |
Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis |
title_full_unstemmed |
Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis |
title_sort |
Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis |
dc.creator.none.fl_str_mv |
Martin, Anandi Paasch, Fabienne Docx, Sven Fissette, Krista Imperiale, Belén Rocío Ribón, Wellman González, Liliana Andrea Werngren, Jim Engström, Anna Skenders, Girts Juréen, Pontus Hoffner, Sven Del Portillo, Patricia Morcillo, Nora Susana Palomino, Juan Carlos |
author |
Martin, Anandi |
author_facet |
Martin, Anandi Paasch, Fabienne Docx, Sven Fissette, Krista Imperiale, Belén Rocío Ribón, Wellman González, Liliana Andrea Werngren, Jim Engström, Anna Skenders, Girts Juréen, Pontus Hoffner, Sven Del Portillo, Patricia Morcillo, Nora Susana Palomino, Juan Carlos |
author_role |
author |
author2 |
Paasch, Fabienne Docx, Sven Fissette, Krista Imperiale, Belén Rocío Ribón, Wellman González, Liliana Andrea Werngren, Jim Engström, Anna Skenders, Girts Juréen, Pontus Hoffner, Sven Del Portillo, Patricia Morcillo, Nora Susana Palomino, Juan Carlos |
author2_role |
author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
DRUG RESISTANCE RESAZURIN SECOND-LINE DRUGS TUBERCULOSIS |
topic |
DRUG RESISTANCE RESAZURIN SECOND-LINE DRUGS TUBERCULOSIS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Objectives: To perform a multicentre study to evaluate the performance of the colorimetric redox indicator (CRI) assay and to establish the MICs and critical concentrations of rifampicin, isoniazid, ofloxacin, kanamycin and capreomycin. Methods: The study was carried out in two phases. Phase I determined the MIC of each drug. Phase II established critical concentrations for the five drugs tested by the CRI assay compared with the conventional proportion method. Results: Phase I: a strain was considered resistant by the CRI assay if the MIC was 0.5 mg/L for rifampicin, 0.25 mg/L for isoniazid, 4.0 mg/L for ofloxacin and 5.0 mg/L for kanamycin and capreomycin. Sensitivity was 99.1% for isoniazid and 100% for the other drugs and specificity was 97.9% for capreomycin and 100% for the other drugs. Phase II: the critical concentration was 0.5 mg/L for rifampicin, 0.25 mg/L for isoniazid, 2.0 mg/L for ofloxacin and 2.5 mg/L for kanamycin and capreomycin giving an overall accuracy of 98.4%, 96.6%, 96.7%, 98.3% and 90%, respectively. Conclusions: Results demonstrate that the CRI assay is an accurate method for the rapid detection of XDR Mycobacterium tuberculosis. The CRI assay is faster than the conventional drug susceptibility testing method using solid medium, has the same turnaround time as the BACTEC MGIT 960 system, but is less expensive, and could be an adequate method for low-income countries. Fil: Martin, Anandi. Institute of Tropical Medicine; Bélgica Fil: Paasch, Fabienne. Institute of Tropical Medicine; Bélgica Fil: Docx, Sven. Institute of Tropical Medicine; Bélgica Fil: Fissette, Krista. Institute of Tropical Medicine; Bélgica Fil: Imperiale, Belén Rocío. Provincia de Buenos Aires. Ministerio de Salud. Hospital "Dr. Antonio A. Cetrángolo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Ribón, Wellman. Universidad Industrial Santander; Colombia Fil: González, Liliana Andrea. Universidad Industrial Santander; Colombia Fil: Werngren, Jim. Swedish Institute for Infectious Disease Control; Suecia Fil: Engström, Anna. Swedish Institute for Infectious Disease Control; Suecia Fil: Skenders, Girts. No especifíca; Fil: Juréen, Pontus. Swedish Institute for Infectious Disease Control; Suecia Fil: Hoffner, Sven. Swedish Institute for Infectious Disease Control; Suecia Fil: Del Portillo, Patricia. No especifíca; Fil: Morcillo, Nora Susana. Provincia de Buenos Aires. Ministerio de Salud. Hospital "Dr. Antonio A. Cetrángolo"; Argentina Fil: Palomino, Juan Carlos. Institute of Tropical Medicine; Bélgica |
description |
Objectives: To perform a multicentre study to evaluate the performance of the colorimetric redox indicator (CRI) assay and to establish the MICs and critical concentrations of rifampicin, isoniazid, ofloxacin, kanamycin and capreomycin. Methods: The study was carried out in two phases. Phase I determined the MIC of each drug. Phase II established critical concentrations for the five drugs tested by the CRI assay compared with the conventional proportion method. Results: Phase I: a strain was considered resistant by the CRI assay if the MIC was 0.5 mg/L for rifampicin, 0.25 mg/L for isoniazid, 4.0 mg/L for ofloxacin and 5.0 mg/L for kanamycin and capreomycin. Sensitivity was 99.1% for isoniazid and 100% for the other drugs and specificity was 97.9% for capreomycin and 100% for the other drugs. Phase II: the critical concentration was 0.5 mg/L for rifampicin, 0.25 mg/L for isoniazid, 2.0 mg/L for ofloxacin and 2.5 mg/L for kanamycin and capreomycin giving an overall accuracy of 98.4%, 96.6%, 96.7%, 98.3% and 90%, respectively. Conclusions: Results demonstrate that the CRI assay is an accurate method for the rapid detection of XDR Mycobacterium tuberculosis. The CRI assay is faster than the conventional drug susceptibility testing method using solid medium, has the same turnaround time as the BACTEC MGIT 960 system, but is less expensive, and could be an adequate method for low-income countries. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-04 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/192105 Martin, Anandi; Paasch, Fabienne; Docx, Sven; Fissette, Krista; Imperiale, Belén Rocío; et al.; Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis; Oxford University Press; Journal of Antimicrobial Chemotherapy; 66; 4; 4-2011; 827-833 0305-7453 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/192105 |
identifier_str_mv |
Martin, Anandi; Paasch, Fabienne; Docx, Sven; Fissette, Krista; Imperiale, Belén Rocío; et al.; Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis; Oxford University Press; Journal of Antimicrobial Chemotherapy; 66; 4; 4-2011; 827-833 0305-7453 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://academic.oup.com/jac/article/66/4/827/723957 info:eu-repo/semantics/altIdentifier/doi/10.1093/jac/dkq527 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Oxford University Press |
publisher.none.fl_str_mv |
Oxford University Press |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613906695192576 |
score |
13.070432 |